Insightec

This study is testing a device called ExAblate 4000 that uses focused ultrasound waves to destroy benign (non-cancerous) brain tumors without making any cuts in the skin. It involves 20 children and young adults with centrally located brain tumors that need treatment. The main go…

This study tests a non-invasive treatment using focused ultrasound to target a small area in the brain involved in movement. It is for people aged 30-65 with early-stage Parkinson's disease (diagnosed less than 5 years) whose symptoms are mainly on one side. The goal is to see if…

This study tests whether a device called ExAblate can safely open the blood-brain barrier in people with Alzheimer's disease. The goal is to see if this helps clear harmful brain proteins and improve symptoms. About 50 adults aged 50-85 with probable Alzheimer's will receive the …